A New Language for Gastric Mapping

The Auckland Classification defines body surface gastric mapping phenotypes and sets priorities for clinical validation

Category	Detail
Condition	Chronic Gastroduodenal Disorders
Key Mechanisms	Body Surface Gastric Mapping (BSGM) measures the stomach’s electrical activity and integrates it with symptom and gut-brain health assessments.
Target Population	Individuals with chronic gastroduodenal disorders, particularly those with normal standard test results but persistent symptoms.
Care Setting	Clinical and research settings for diagnostic evaluation.

Auckland Classification provides standardized criteria for interpreting BSGM findings.
BSGM complements existing diagnostic tests like endoscopy and gastric emptying studies.
The classification aims to reduce diagnostic uncertainty for patients with chronic symptoms.
Standardized terminology and phenotype labels enhance research and clinical decision-making.
Further validation is needed to establish relationships between phenotypes and treatment responses.

Consider the Low Meal Response phenotype for potential better response to prokinetic therapy.

Evaluate symptom patterns and BSGM findings over time to guide clinical assessments.

Further research is required to confirm the clinical utility and cost-effectiveness of BSGM.

Patients with chronic gastroduodenal disorders experiencing diagnostic challenges.

Objective characterization of symptoms may lead to more focused clinical assessments.

Integrate BSGM findings with existing diagnostic tools for a comprehensive evaluation.
Utilize the Auckland Classification for consistent reporting and comparison of BSGM results.
Prioritize prospective validation of phenotypes to inform future clinical guidelines.